Lisa A Waiwaiole, Michelle L Henninger, Daniel J Pihlstrom, Michael C Leo, David M Mosen, Allison L Naleway
{"title":"Dental provider vaccination recommendations, a parent accepted strategy for disease prevention","authors":"Lisa A Waiwaiole, Michelle L Henninger, Daniel J Pihlstrom, Michael C Leo, David M Mosen, Allison L Naleway","doi":"10.15406/jcpcr.2019.10.00404","DOIUrl":null,"url":null,"abstract":"Recommended vaccines for adolescents between the ages of 11-17 years in the United States (U.S.) are tetanus-diphtheriaacellular pertussis (Tdap), meningococcal conjugate (MCV4), human papillomavirus (HPV), and seasonal influenza (flu). While U.S. vaccine coverage rates for Tdap and MCV4 approach Healthy People target goals of 80%, coverage rates are 43% for HPV1 and 49% for flu.2 The American Academy of Paediatrics cites the need for improvement in vaccination rates.3 A model suggests that increasing HPV vaccine coverage to 80% for 13 birth cohorts of U.S. girls 12 and under could avoid 53,300 lifetime cervical cancer cases.4 Given that most flu-associated pediatric deaths are in children who were not vaccinated, estimates show that vaccination could reduce risk of death by 50% for children in high-risk categories and two-thirds for children with no high-risk conditions.5 With pertussis disease rates increasing,6 increased vaccination coverage could prevent death and disease. Renewed strategies are needed to address low vaccination rates.","PeriodicalId":15185,"journal":{"name":"Journal of Cancer Prevention & Current Research","volume":"6 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Prevention & Current Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/jcpcr.2019.10.00404","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Recommended vaccines for adolescents between the ages of 11-17 years in the United States (U.S.) are tetanus-diphtheriaacellular pertussis (Tdap), meningococcal conjugate (MCV4), human papillomavirus (HPV), and seasonal influenza (flu). While U.S. vaccine coverage rates for Tdap and MCV4 approach Healthy People target goals of 80%, coverage rates are 43% for HPV1 and 49% for flu.2 The American Academy of Paediatrics cites the need for improvement in vaccination rates.3 A model suggests that increasing HPV vaccine coverage to 80% for 13 birth cohorts of U.S. girls 12 and under could avoid 53,300 lifetime cervical cancer cases.4 Given that most flu-associated pediatric deaths are in children who were not vaccinated, estimates show that vaccination could reduce risk of death by 50% for children in high-risk categories and two-thirds for children with no high-risk conditions.5 With pertussis disease rates increasing,6 increased vaccination coverage could prevent death and disease. Renewed strategies are needed to address low vaccination rates.